ReWalk Robotics Hopes to Raise $50M in IPO
From Boston Herald:
A company with U.S. headquarters in Marlborough that was recently awarded FDA approval to sell its robotic exoskeletons for paraplegics plans to raise $50 million in an IPO this week, possibly on Friday.
Israeli-based ReWalk Robotics is planning to sell 3.5 million shares for between $14 and $16 each, which puts it at the low end of the 13 local health care companies which have gone public since the beginning of the year, more than any other year in history. Most of those have been biotech companies, however, making ReWalk the first robotics-focused company to do so in at least a couple of years... (cont'd)
Featured Product
Boston Dynamics Webinar - Why Humanoids Are the Future of Manufacturing
Join us November 18th for this Webinar as we reflect on what we've learned by observing factory floors, and why we've grown convinced that chasing generalization in manipulation—both in hardware and behavior—isn't just interesting, but necessary. We'll discuss AI research threads we're exploring at Boston Dynamics to push this mission forward, and highlight opportunities our field should collectively invest more in to turn the humanoid vision, and the reinvention of manufacturing, into a practical, economically viable product.
